The European Medicine Agency (EMA) approved a vaccine from the coronavirus production Pfizer and Biontech for use among children aged 5 to 11 years old, reports Anadolu.
The appropriate decision is made according to the results of testing about 2,000 children. The side effects of the vaccination were the same as other age groups: redness in the field of vaccine administration, fatigue, head and muscular pain.
It is noted that this vaccine is currently approved for use among people from 12 years and older. Dosage that will be applied in the age group from 5 to 11 years will be less.